The use of induced pluripotent stem cells (iPSCs) has garnered attention due to their potential to treat diseases and injuries. The biomanufacturing process of iPSC requires careful control and monitoring for consistency and quality. Key to this process is the use of optimized cell culture media formulations, free from contaminants and adhering to regulatory standards. The use of Recombinant Insulin in chemically defined media adheres to GMP standards and enhances iPSC proliferation and quality, without affecting pluripotency over several passages.
Where can I learn more?
For more information visit our case study about enhancing hiPSC culture quality.
